Circulating intercellular adhesion molecule-1 (ICAM-1) as an early and sensitive marker for virus-induced T cell activation

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Circulating intercellular adhesion molecule-1 (ICAM-1) as an early and sensitive marker for virus-induced T cell activation. / Christensen, Jan Pravsgaard; Johansen, J; Marker, O; Thomsen, Allan Randrup.

In: Clinical and Experimental Immunology, Vol. 102, No. 2, 1995, p. 268-73.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Christensen, JP, Johansen, J, Marker, O & Thomsen, AR 1995, 'Circulating intercellular adhesion molecule-1 (ICAM-1) as an early and sensitive marker for virus-induced T cell activation', Clinical and Experimental Immunology, vol. 102, no. 2, pp. 268-73.

APA

Christensen, J. P., Johansen, J., Marker, O., & Thomsen, A. R. (1995). Circulating intercellular adhesion molecule-1 (ICAM-1) as an early and sensitive marker for virus-induced T cell activation. Clinical and Experimental Immunology, 102(2), 268-73.

Vancouver

Christensen JP, Johansen J, Marker O, Thomsen AR. Circulating intercellular adhesion molecule-1 (ICAM-1) as an early and sensitive marker for virus-induced T cell activation. Clinical and Experimental Immunology. 1995;102(2):268-73.

Author

Christensen, Jan Pravsgaard ; Johansen, J ; Marker, O ; Thomsen, Allan Randrup. / Circulating intercellular adhesion molecule-1 (ICAM-1) as an early and sensitive marker for virus-induced T cell activation. In: Clinical and Experimental Immunology. 1995 ; Vol. 102, No. 2. pp. 268-73.

Bibtex

@article{a5bf8200df7211ddb5fc000ea68e967b,
title = "Circulating intercellular adhesion molecule-1 (ICAM-1) as an early and sensitive marker for virus-induced T cell activation",
abstract = "The effect of systemic virus infection on the level of circulating ICAM-1 (cICAM-1) in serum, and the role of virus-activated T cells in this context, were studied using the murine lymphocytic choriomeningitis virus infection as primary model system. A marked virus-induced elevation in cICAM-1 in serum was revealed, the presence of which coincided with the phase of virus-induced T cell activation. However, high levels of cICAM-1 in serum were observed well before maximal T cell activation could be demonstrated. No increase in cICAM-1 was observed in the serum of infected T cell-deficient nude mice, clearly demonstrating that T cells were mandatory. Analysis of MHC class I and MHC class II-deficient mice revealed that either CD4+ or CD8+ T cells alone are sufficient, despite a markedly reduced inflammatory exudate in the former animals. These results indicate that virus-activated T cells induce shedding of ICAM-1 into the circulation, and this parameter may be used as an early and sensitive marker for immune activation.",
author = "Christensen, {Jan Pravsgaard} and J Johansen and O Marker and Thomsen, {Allan Randrup}",
note = "Keywords: Animals; Biological Markers; Intercellular Adhesion Molecule-1; Lymphocyte Activation; Lymphocytic Choriomeningitis; Lymphocytic choriomeningitis virus; Mice; Mice, Inbred BALB C; Mice, Nude; Solubility; T-Lymphocytes; Time Factors; Vesicular stomatitis Indiana virus",
year = "1995",
language = "English",
volume = "102",
pages = "268--73",
journal = "Clinical and Experimental Immunology, Supplement",
issn = "0964-2536",
publisher = "Wiley-Blackwell",
number = "2",

}

RIS

TY - JOUR

T1 - Circulating intercellular adhesion molecule-1 (ICAM-1) as an early and sensitive marker for virus-induced T cell activation

AU - Christensen, Jan Pravsgaard

AU - Johansen, J

AU - Marker, O

AU - Thomsen, Allan Randrup

N1 - Keywords: Animals; Biological Markers; Intercellular Adhesion Molecule-1; Lymphocyte Activation; Lymphocytic Choriomeningitis; Lymphocytic choriomeningitis virus; Mice; Mice, Inbred BALB C; Mice, Nude; Solubility; T-Lymphocytes; Time Factors; Vesicular stomatitis Indiana virus

PY - 1995

Y1 - 1995

N2 - The effect of systemic virus infection on the level of circulating ICAM-1 (cICAM-1) in serum, and the role of virus-activated T cells in this context, were studied using the murine lymphocytic choriomeningitis virus infection as primary model system. A marked virus-induced elevation in cICAM-1 in serum was revealed, the presence of which coincided with the phase of virus-induced T cell activation. However, high levels of cICAM-1 in serum were observed well before maximal T cell activation could be demonstrated. No increase in cICAM-1 was observed in the serum of infected T cell-deficient nude mice, clearly demonstrating that T cells were mandatory. Analysis of MHC class I and MHC class II-deficient mice revealed that either CD4+ or CD8+ T cells alone are sufficient, despite a markedly reduced inflammatory exudate in the former animals. These results indicate that virus-activated T cells induce shedding of ICAM-1 into the circulation, and this parameter may be used as an early and sensitive marker for immune activation.

AB - The effect of systemic virus infection on the level of circulating ICAM-1 (cICAM-1) in serum, and the role of virus-activated T cells in this context, were studied using the murine lymphocytic choriomeningitis virus infection as primary model system. A marked virus-induced elevation in cICAM-1 in serum was revealed, the presence of which coincided with the phase of virus-induced T cell activation. However, high levels of cICAM-1 in serum were observed well before maximal T cell activation could be demonstrated. No increase in cICAM-1 was observed in the serum of infected T cell-deficient nude mice, clearly demonstrating that T cells were mandatory. Analysis of MHC class I and MHC class II-deficient mice revealed that either CD4+ or CD8+ T cells alone are sufficient, despite a markedly reduced inflammatory exudate in the former animals. These results indicate that virus-activated T cells induce shedding of ICAM-1 into the circulation, and this parameter may be used as an early and sensitive marker for immune activation.

M3 - Journal article

C2 - 7586677

VL - 102

SP - 268

EP - 273

JO - Clinical and Experimental Immunology, Supplement

JF - Clinical and Experimental Immunology, Supplement

SN - 0964-2536

IS - 2

ER -

ID: 9639805